Moderna Sticks With Its Forecast Covid-19 Vaccine Sales
Published
Moderna is sticking by its forecast range for 2023 Covid-19 vaccine sales, after rival Pfizer cut the sales outlook for its own shot , citing lower-than-expected vaccination rates. Moderna said Monday it remains comfortable with its prediction of $6 billion to $8 billion in Covid-19 vaccine sales…
#pfizer